| Identification of the cell-intrinsic and-extrinsic pathways downstream of EGFR and IFNγ that induce PD-L1 expression in head and neck cancer F Concha-Benavente, RM Srivastava, S Trivedi, Y Lei, U Chandran, ... Cancer research 76 (5), 1031-1043, 2016 | 330 | 2016 |
| PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer BA Kansy, F Concha-Benavente, RM Srivastava, HB Jie, G Shayan, Y Lei, ... Cancer research 77 (22), 6353-6364, 2017 | 201 | 2017 |
| Anti-EGFR targeted monoclonal antibody isotype influences antitumor cellular immunity in head and neck cancer patients S Trivedi, RM Srivastava, F Concha-Benavente, S Ferrone, ... Clinical Cancer Research 22 (21), 5229-5237, 2016 | 159 | 2016 |
| PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients F Concha-Benavente, B Kansy, J Moskovitz, J Moy, U Chandran, ... Cancer immunology research 6 (12), 1548-1560, 2018 | 145 | 2018 |
| Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: efficacy and safety in CheckMate 141 by prior cetuximab use RL Ferris, L Licitra, J Fayette, C Even, G Blumenschein Jr, KJ Harrington, ... Clinical Cancer Research 25 (17), 5221-5230, 2019 | 139 | 2019 |
| CD137 stimulation enhances cetuximab-induced natural killer: dendritic cell priming of antitumor T-cell immunity in patients with head and neck cancer RM Srivastava, S Trivedi, F Concha-Benavente, SP Gibson, C Reeder, ... Clinical Cancer Research 23 (3), 707-716, 2017 | 126 | 2017 |
| Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a … R Haddad, F Concha‐Benavente, G Blumenschein Jr, J Fayette, J Guigay, ... Cancer 125 (18), 3208-3218, 2019 | 77 | 2019 |
| STAT1-induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy in HNC patients RM Srivastava, S Trivedi, F Concha-Benavente, J Hyun-Bae, L Wang, ... Cancer immunology research 3 (8), 936-945, 2015 | 74 | 2015 |
| Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells F Concha-Benavente, R Srivastava, S Ferrone, RL Ferris Oral oncology 58, 52-58, 2016 | 73 | 2016 |
| Nimotuzumab induces NK cell activation, cytotoxicity, dendritic cell maturation and expansion of EGFR-specific T cells in head and neck cancer patients Z Mazorra, A Lavastida, F Concha-Benavente, A Valdés, RM Srivastava, ... Frontiers in pharmacology 8, 382, 2017 | 59 | 2017 |
| STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV+ status in head and neck cancer S Lu, F Concha-Benavente, G Shayan, RM Srivastava, SP Gibson, ... Oral oncology 78, 186-193, 2018 | 51 | 2018 |
| Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 … R Haddad, G Blumenschein, J Fayette, J Guigay, AD Colevas, L Licitra, ... Annals of Oncology 28, v372-v373, 2017 | 50 | 2017 |
| Immune biomarkers of anti-EGFR monoclonal antibody therapy S Trivedi, F Concha-Benavente, RM Srivastava, HB Jie, SP Gibson, ... Annals of Oncology 26 (1), 40-47, 2015 | 50 | 2015 |
| EGFR-mediated tumor immunoescape: the imbalance between phosphorylated STAT1 and phosphorylated STAT3 F Concha-Benavente, RM Srivastava, S Ferrone, RL Ferris Oncoimmunology 2 (12), e27215, 2013 | 42 | 2013 |
| Reversing EGFR mediated immunoescape by targeted monoclonal antibody therapy F Concha-Benavente, RL Ferris Frontiers in pharmacology 8, 255575, 2017 | 36 | 2017 |
| Inhibition of soluble tumor necrosis factor prevents chemically induced carcinogenesis in mice A Sobo-Vujanovic, L Vujanovic, AB DeLeo, F Concha-Benavente, ... Cancer immunology research 4 (5), 441-451, 2016 | 33 | 2016 |
| LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance W Guo, Y Wang, M Yang, Z Wang, Y Wang, S Chaurasia, Z Wu, M Zhang, ... Science Advances 7 (7), eabb3555, 2021 | 32 | 2021 |
| Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell–Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti–Programmed Death-1 TM Garcia-Bates, E Kim, F Concha-Benavente, S Trivedi, RB Mailliard, ... The Journal of Immunology 196 (6), 2870-2878, 2016 | 29 | 2016 |
| EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer W Ma, F Concha-Benavente, SJAM Santegoets, MJP Welters, I Ehsan, ... PLoS One 13 (9), e0203402, 2018 | 28 | 2018 |
| Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis R Fletcher, J Tong, D Risnik, BJ Leibowitz, YJ Wang, ... Oncogene 40 (11), 2035-2050, 2021 | 25 | 2021 |
